DJIA 18,030.21 0.00 0.00%
NASDAQ 4,773.47 0.00 0.00%
S&P 500 2,081.88 0.00 0.00%
market minute promo

Express Scripts (NASDAQ: ESRX)



company name or ticker
Company Photos
(Click to zoom)

AmerisourceBergen's Move To Go Big Is The Right Rx

My Dividend Stocks Aren't For Sale

Can Healthways (HWAY) Surprise This Earnings Season? - Analyst Blog

Express Scripts Holding (ESRX) Shares Cross Above 200 DMA

CVS Health Corporation (CVS) Ex-Dividend Date Scheduled for October 21, 2014

Comparing America's 3 Largest Health Plan Companies

Walgreen: Too Cheap To Be Ignored?

IHF, ESRX, WLP, AET: ETF Outflow Alert

2015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality And Performance Rating

2015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality And Performance Rating

Gilead Sciences, inc. Stock's Green Light Sparks Offensive

Gilead Sciences will need to convince healthcare payers to prescribe its new hepatitis C drug Harvoni.